dc.contributor.author |
Павловская, Е. Н. |
ua |
dc.date.accessioned |
2025-07-14T10:57:15Z |
|
dc.date.available |
2025-07-14T10:57:15Z |
|
dc.date.issued |
1999 |
|
dc.identifier.citation |
Павловская Е. Н. Влияние системы активной медикаментозной реабилитации с помощью средств белковосинтетического усиления на восстановление трудоспособности и социальную реадаптацию больных, перенесших инфаркт миокарда // Вісник морської медицини. 1999. №1. С. 84–86. |
ru |
dc.identifier.issn |
2707-1324 |
|
dc.identifier.uri |
https://repo.odmu.edu.ua:443/xmlui/handle/123456789/17968 |
|
dc.description.abstract |
They had offered a system of active medicamental rehabilitation with means of protein-synthetic reinforcement , i.e. solcoseril and actovegin with retabolil. The patients had been divided into two groups, comparative by age , sex and severity of the disease. The first group took high doses of the drugs mentioned above during 30–45 days after discharge from the hospital (solcoseril 8.0 ml per day i/m and 2.0 ml of retabolil i/m once in 5–7 days during 6 weeks). The second group took super intensive treatment with solcoseril in the same doses during 45 days and retabolil during 60 days. This course was conducted twice a year. Indices of work ability recovery was 76.0%in the first group and 82.8% in the second one. The date obtained proved positive clinical effect of the means of protein-synthetic reinforcement in postmyocardial infarction patients. |
en |
dc.language.iso |
ru |
en |
dc.subject |
myocardial infarction |
en |
dc.subject |
medicamental rehabilitation |
en |
dc.subject |
social adaptation |
en |
dc.subject |
work ability |
en |
dc.title |
Влияние системы активной медикаментозной реабилитации с помощью средств белковосинтетического усиления на восстановление трудоспособности и социальную реадаптацию больных, перенесших инфаркт миокарда |
ru |
dc.title.alternative |
Influence of active medicamental rehabilitation system with means of protein-synthetic reinforcement on the work-ability recovery and social adaptation in postmyocardial infarction patients. |
en |
dc.type |
Article |
en |